개정된 대한췌장담도학회 총담관결석 진료 가이드라인: 개발 목적과 과정 = Revised Clinical Practice Guideline of Korean Pancreatobiliary Association for Common Bile Duct Stones: Purpose and Process of Guidelines

국문 초록 (Abstract)

2013년 본 학회에서 총담관결석 진료 권고안이 발간된 이후, 최신의 치료 기술을 반영하면서도 국내 의료 환경을 고려한 임상진료지침 개정에 대한 요구가 있었다. 이에 대한췌장담도학회는 최근까지 발표된 국내외의 총담관결석과 관련된 중요 문헌을 수집, 분석 및 고찰 후, 전문가 집단을 대상으로 설문조사 시행, 임상진료지침을 개정하였다. 개정된 임상진료지침은 1) 총담관결석의 진단, 2) 총담관결석의 내시경 치료, 3) 난치성총담관결석의 내시경 치료 3개 분야로 작성되었으며, 총 13개의 권고사항과 그 근거를 제시하는 형태로 기술하였다.

다국어 초록 (Multilingual Abstract)

Common bile duct (CBD) stones carry a risk of complications including biliary obstruction, acute cholangitis and pancreatitis. Endoscopic retrograde cholangiopancreatography (ERCP) is regarded as the standard of treatment for CBD stones nowadays. However, ERCP can cause severe adverse events such as bleeding, post-ERCP pancreatitis and perforation. Therefore, it is important to provide practical guideline to manage CBD stones for clinicians. The Korean Pancreatobiliary Association (KPBA) established the first Korean guidelines for the management of CBD stones in 2013. Taking together the recently developed techniques for CBD stones and evidence newly obtained, the committee of the KPBA decided to perform an extensive revision of the guidelines. These revised guidelines were developed based on consensusbased guideline using Delphi methods. The main topics of these guidelines fall under the following topics: 1) diagnosis, 2) endoscopic management, 3) endoscopic management for difficult CBD stones. The specific recommendations are presented with the quality of evidence and classification of recommendations.